Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains
Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click for my DNLI stock update.
Illinois Department of Public Health adds four new conditions for medical cannabis use
Medical cannabis has been shown to offer an effective means of relief from a variety of debilitating medical conditions and ...